基準マーカーの世界市場2020-2027:モダリティ別(超音波、CT/CBCT)、製品別、用途別、エンドユーザー別

◆英語タイトル:Fiducial Markers Market Size, Share & Trends Analysis Report By Modality (Ultrasound, CT/CBCT), By Product (Gold, Gold Combination), By Application (Prostate, Lung, Breast Cancer), By End User, And Segment Forecasts, 2020 - 2027
◆商品コード:GV20JN111
◆発行会社(リサーチ会社):Grand View Research
◆発行日:2020年4月
◆ページ数:130
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:クローバル
◆販売価格オプション(消費税別)
Single UserUSD5,950 ⇒換算¥618,800見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算¥722,800見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算¥930,800見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGrand View Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Grand View Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本調査レポートでは、基準マーカーの世界市場を調査・分析し、調査手法・範囲、エグゼクティブサマリー、市場の要因・動向・範囲、モダリティ別(超音波、CT/CBCT)分析、製品別分析、用途別分析、エンドユーザー別分析、地域別分析、競争状況など、今後の市場展望をまとめております。
・調査手法・範囲
・エグゼクティブサマリー
・市場の要因・動向・範囲
・基準マーカーの世界市場規模:モダリティ別(超音波、CT/CBCT)
・基準マーカーの世界市場規模:製品別
・基準マーカーの世界市場規模:用途別
・基準マーカーの世界市場規模:エンドユーザー別
・基準マーカーの世界市場規模:地域別
・競争状況
【レポートの概要】

The global fiducial markers market size is estimated to reach USD 142.0 million by 2027 registering a CAGR of 4.2%, according to a new report by Grand View Research, Inc. Increasing prevalence of cancer and growing adoption of radiotherapy procedures are the factors expected to contribute to the market growth. Fiducial markers are widely used in external beam radiotherapy procedures. Therefore, increasing number of external beam radiotherapy procedures is also expected to boost the adoption of these markers. In addition, over most of the cancer patients receive radiation therapy, which in turn, is increasing the product demand.

Rising awareness about the safety and efficiency of advanced radiotherapy techniques, such as stereotactic radiosurgery, intensity-modulated radiotherapy, and image guide radiotherapy, in cancer treatment is expected to boost the market growth. Moreover, several initiatives undertaken by various governments for the development of new radiotherapy centers through direct funding or tax waive-off will aid in market growth.

On the other hand, availability of alternative treatment methods, such as chemotherapy, hormonal therapy, and surgery, is expected to have a negative impact on the product demand. Furthermore, with the advent of advanced imaging modalities, such as PET-based LINAC system, eliminates the need for fiducial markers hampering the market growth. However, high cost of PET-based LINAC systems is expected to contribute to the increased usage of fiducial markers for radiotherapy.

Further key findings from the study suggest:

• Gold fiducial markers segment held the largest market share in 2019 and is expected to expand at a healthy CAGR over the forecast period owing to product advantages, such as biocompatibility and enhanced visibility across multiple imaging modalities including CT, MRI, ultrasound, and fluoroscopy

• Based on application, prostate cancer segment held the largest market share in 2019 and is expected to register a significant CAGR over the forecast period

• Based on end user, radiotherapy center segment is projected to register the fastest CAGR during the forecast period

• North America is estimated to be the largest regional fiducial markers market over the forecast period due to growing number of cancer cases and adoption of advanced technologies

• Some of the prominent companies in the global market are CIVCO Radiotherapy; IZI Medical Products, LLC; Naslund Medical AB; Medtronic PLC; QlRad, Inc.; QFIX; Boston Scientific Corp.; Nanovi A/S; Eckert & Ziegler; and IBA Dosimetry GmbH

【レポートの目次】

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Product
1.1.2. Modality
1.1.3. Application
1.1.4. End-user
1.1.5. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.3.5.1. Data for primary interviews in North America
1.3.5.2. Data for primary interviews in Europe
1.3.5.3. Data for primary interviews in Asia Pacific
1.3.5.4. Data for primary interviews in Latin America
1.3.5.5. Data for Primary interviews in MEA
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Modality outlook
2.2.3. Application outlook
2.2.4. End-user outlook
2.2.5. Regional outlook
2.3. Competitive Insights
Chapter 3. Fiducial Markers Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Industry Value Chain Analysis
3.3.1. Reimbursement framework
3.4. Market Dynamics
3.4.1. Market driver analysis
3.4.1.1. Increasing prevalence of cancer
3.4.1.2. Rising acceptance of radiotherapy procedures
3.4.1.3. Increasing public and private funding in cancer research
3.4.2. Market restraint analysis
3.4.2.1. Availability of alternate treatment options
3.4.2.2. Lack of skilled professionals
3.5. Fiducial Markers Market Analysis Tools
3.5.1. Industry analysis – Porter’s
3.5.1.1. Supplier power
3.5.1.2. Buyer power
3.5.1.3. Substitution threat
3.5.1.4. Threat of new entrant
3.5.1.5. Competitive rivalry
3.5.2. PESTEL analysis
3.5.2.1. Political landscape
3.5.2.2. Technological landscape
3.5.2.3. Economic landscape
3.5.3. Major deals & strategic alliances analysis
3.5.4. Market entry strategies
Chapter 4. Global Fiducial Markers Market: Product Estimates & Trend Analysis
4.1. Definitions and Scope
4.1.1. Gold
4.1.2. Gold Combination
4.1.3. Polymer
4.1.4. Other Metal
4.1.5. Liquid
4.2. Product Market Share, 2019 & 2027
4.3. Segment Dashboard
4.4. Global Fiducial Markers Market by Product Outlook
4.5. Market Size & Forecasts and Trend Analyses, 2016 to 2027 for the following
4.5.1. Gold
4.5.1.1. Market estimates and forecast, 2016 – 2027 (Revenue, USD Million, Volume, Units)
4.5.2. Gold Combination
4.5.2.1. Market estimates and forecast, 2016 – 2027 (Revenue, USD Million, Volume, Units)
4.5.3. Polymer
4.5.3.1. Market estimates and forecast, 2016 – 2027 (Revenue, USD Million, Volume, Units)
4.5.4. Other Metals
4.5.4.1. Market estimates and forecast, 2016 – 2027 (Revenue, USD Million, Volume, Units)
4.5.5. Liquid
4.5.5.1. Market estimates and forecast, 2016 – 2027 (Revenue, USD Million, Volume, Units)
Chapter 5. Global Fiducial Markers Market: Modality Estimates & Trend Analysis
5.1. Definitions and Scope
5.1.1. CT/CBCT
5.1.2. MRI
5.1.3. Ultrasound
5.1.4. X-Ray
5.2. Modality Share, 2019 & 2027
5.3. Segment Dashboard
5.4. Global Fiducial Markers Market by Modality Outlook
5.5. Market Size & Forecasts and Trend Analyses, 2016 to 2027 for the following
5.5.1. CT/CBCT
5.5.1.1. Market estimates and forecast, 2016 – 2027 (Revenue, USD Million)
5.5.2. MRI
5.5.2.1. Market estimates and forecast, 2016 – 2027 (Revenue, USD Million)
5.5.3. Ultrasound
5.5.3.1. Market estimates and forecast, 2016 – 2027 (USD Million)
5.5.4. X-Ray
5.5.4.1. Market estimates and forecast, 2016 – 2027 (USD Million)
Chapter 6. Global Fiducial Markers Market: Application Estimates & Trend Analysis
6.1. Definitions and Scope
6.1.1. Breast Cancer
6.1.2. Lung Cancer
6.1.3. Prostate Cancer
6.1.4. Head and Neck Cancer
6.1.5. Other
6.2. Application Share, 2019 & 2027
6.3. Segment Dashboard
6.4. Global Fiducial Markers Market by Application Outlook
6.5. Market Size & Forecasts and Trend Analyses, 2016 to 2027 for the following
6.5.1. Breast cancer
6.5.1.1. Market estimates and forecast, 2016 – 2027 (Revenue, USD Million)
6.5.2. Lung cancer
6.5.2.1. Market estimates and forecast, 2016 – 2027 (Revenue, USD Million)
6.5.3. Prostate cancer
6.5.3.1. Market estimates and forecast, 2016 – 2027 (USD Million)
6.5.4. Head and neck cancer
6.5.4.1. Market estimates and forecast, 2016 – 2027 (USD Million)
6.5.5. Others
6.5.5.1. Market estimates and forecast, 2016 – 2027 (USD Million)
Chapter 7. Global Fiducial Markers Market: End-User Estimates & Trend Analysis
7.1. Definitions and Scope
7.1.1. Hospitals
7.1.2. Radiotherapy Center
7.1.3. Academic and Research Center
7.2. End-User, 2019 & 2027
7.3. Segment Dashboard
7.4. Global Fiducial Markers Market by End-user Outlook
7.5. Market Size & Forecasts and Trend Analyses, 2016 to 2027 for the following
7.5.1. Hospitals
7.5.1.1. Market estimates and forecast, 2016 – 2027 (Revenue, USD Million)
7.5.2. Radiotherapy Center
7.5.2.1. Market estimates and forecast, 2016 – 2027 (Revenue, USD Million)
7.5.3. Academic and Research Center
7.5.3.1. Market estimates and forecast, 2016 – 2027 (Revenue, USD Million)
Chapter 8. Global Fiducial Markers Market: Regional Estimates & Trend Analysis
8.1. Regional Market Share Analysis, 2019 & 2027
8.2. Regional Market Dashboard
8.3. Global Regional Market Snapshot
8.4. Regional Market Share and Leading Players, 2019
8.4.1. North America
8.4.2. Europe
8.4.3. Asia Pacific
8.4.4. Latin America
8.4.5. Middle East and Africa
8.5. SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
8.5.1. North America
8.5.2. Europe
8.5.3. Asia Pacific
8.5.4. Latin America
8.5.5. Middle East and Africa
8.6. Market Size, & Forecasts, Volume and Trend Analysis, 2019 to 2027:
8.7. North America
8.7.1. U.S.
8.7.1.1. Market estimates and forecast, 2016 – 2027 (Revenue, USD Million)
8.7.2. Canada
8.7.2.1. Market estimates and forecast, 2016 – 2027 (Revenue, USD Million)
8.8. Europe
8.8.1. U.K.
8.8.1.1. Market estimates and forecast, 2016 – 2027 (Revenue, USD Million)
8.8.2. Germany
8.8.2.1. Market estimates and forecast, 2016 – 2027 (Revenue, USD Million)
8.8.3. France
8.8.3.1. Market estimates and forecast, 2016 – 2027 (Revenue, USD Million)
8.8.4. Italy
8.8.4.1. Market estimates and forecast, 2016 – 2027 (Revenue, USD Million)
8.8.5. Spain
8.8.5.1. Market estimates and forecast, 2016 – 2027 (Revenue, USD Million)
8.8.6. Russia
8.8.6.1. Market estimates and forecast, 2016 – 2027 (Revenue, USD Million)
8.8.7. Switzerland
8.8.7.1. Market estimates and forecast, 2016 – 2027 (Revenue, USD Million)
8.8.8. The Netherlands
8.8.8.1. Market estimates and forecast, 2016 – 2027 (Revenue, USD Million)
8.8.9. Sweden
8.8.9.1. Market estimates and forecast, 2016 – 2027 (Revenue, USD Million)
8.8.10. Belgium
8.8.10.1. Market estimates and forecast, 2016 – 2027 (Revenue, USD Million)
8.9. Asia Pacific
8.9.1. Japan
8.9.1.1. Market estimates and forecast, 2016 – 2027 (Revenue, USD Million)
8.9.2. China
8.9.2.1. Market estimates and forecast, 2016 – 2027 (Revenue, USD Million)
8.9.3. India
8.9.3.1. Market estimates and forecast, 2016 – 2027 (Revenue, USD Million)
8.9.4. South Korea
8.9.4.1. Market estimates and forecast, 2016 – 2027 (Revenue, USD Million)
8.9.5. Thailand
8.9.5.1. Market estimates and forecast, 2016 – 2027 (Revenue, USD Million)
8.9.6. Indonesia
8.9.6.1. Market estimates and forecast, 2016 – 2027 (Revenue, USD Million)
8.9.7. Philippines
8.9.7.1. Market estimates and forecast, 2016 – 2027 (Revenue, USD Million)
8.9.8. Taiwan
8.9.8.1. Market estimates and forecast, 2016 – 2027 (Revenue, USD Million)
8.9.9. Malaysia
8.9.9.1. Market estimates and forecast, 2016 – 2027 (Revenue, USD Million)
8.9.10. Singapore
8.9.10.1. Market estimates and forecast, 2016 – 2027 (Revenue, USD Million)
8.10. Latin America
8.10.1. Brazil
8.10.1.1. Market estimates and forecast, 2016 – 2027 (Revenue, USD Million)
8.10.2. Mexico
8.10.2.1. Market estimates and forecast, 2016 – 2027 (Revenue, USD Million)
8.10.3. Argentina
8.10.3.1. Market estimates and forecast, 2016 – 2027 (Revenue, USD Million)
8.10.4. Colombia
8.10.4.1. Market estimates and forecast, 2016 – 2027 (Revenue, USD Million)
8.10.5. Chile
8.10.5.1. Market estimates and forecast, 2016 – 2027 (Revenue, USD Million)
8.11. MEA
8.11.1. South Africa
8.11.1.1. Market estimates and forecast, 2016 – 2027 (Revenue, USD Million)
8.11.2. Saudi Arabia
8.11.2.1. Market estimates and forecast, 2016 – 2027 (Revenue, USD Million)
8.11.3. UAE
8.11.3.1. Market estimates and forecast, 2016 – 2027 (Revenue, USD Million)
8.11.4. Kuwait
8.11.4.1. Market estimates and forecast, 2016 – 2027 (Revenue, USD Million)
8.11.5. Israel
8.11.5.1. Market estimates and forecast, 2016 – 2027 (Revenue, USD Million)
Chapter 9. Competitive Landscape
9.1. Recent Developments & Impact Analysis, By Key Market Participants
9.2. Company/Competitive Categorization
9.2.1. Innovators
9.2.2. Market leaders
9.2.3. Emerging players
9.3. Vendor Landscape
9.3.1. List of key distributors and channel partners
9.3.2. Key customers
9.3.3. Key company market share analysis, 2019
9.4. Public Companies
9.4.1. Company market position analysis (Revenue, geographic presence, product portfolio, key serviceable industries, key alliances)
9.4.2. Company market share/ranking, by region
9.4.3. Competitive dashboard analysis
9.4.3.1. Market differentiators
9.4.3.2. Synergy analysis: major deals and strategic alliances
9.5. Private Companies
9.5.1. List of key emerging companies/technology disruptors/innovators
9.5.2. Funding outlook
9.5.3. Regional network map
9.5.4. Company market position analysis (geographic presence, product portfolio, key alliance, industry experience)
9.5.5. Supplier ranking
9.5.6. Key company profiled
9.5.7. CIVCO Radiotherapy
9.5.7.1. Company overview
9.5.7.2. Financial performance
9.5.7.3. Product benchmarking
9.5.7.4. Strategic initiatives
9.5.8. IZI Medical Products
9.5.8.1. Company overview
9.5.8.2. Financial performance
9.5.8.3. Product benchmarking
9.5.8.4. Strategic initiatives
9.5.9. Naslund Medical AB
9.5.9.1. Company overview
9.5.9.2. Financial performance
9.5.9.3. Product benchmarking
9.5.9.4. Strategic initiatives
9.5.10. Medtronic, Inc.
9.5.10.1. Company overview
9.5.10.2. Financial performance
9.5.10.3. Product benchmarking
9.5.10.4. Strategic Initiative
9.5.11. QlRad Inc.
9.5.11.1. Company overview
9.5.11.2. Financial performance
9.5.11.3. Product benchmarking
9.5.11.4. Strategic initiatives
9.5.12. QFix
9.5.12.1. Company overview
9.5.12.2. Financial performance
9.5.12.3. Product benchmarking
9.5.12.4. Strategic initiatives
9.5.13. Boston Scientific Corporation
9.5.13.1. Company overview
9.5.13.2. Financial performance
9.5.13.3. Product benchmarking
9.5.13.4. Strategic initiatives
9.5.14. Nanovi A/S
9.5.14.1. Company overview
9.5.14.2. Financial performance
9.5.14.3. Product benchmarking
9.5.14.4. Strategic initiatives
9.5.15. Eckert & Ziegler
9.5.15.1. Company overview
9.5.15.2. Financial performance
9.5.15.3. Product benchmarking
9.5.15.4. Strategic initiatives
9.5.16. IBA Dosimetry GmbH
9.5.16.1. Company overview
9.5.16.2. Financial performance
9.5.16.3. Product benchmarking
9.5.16.4. Strategic initiatives

List of Tables

Table 1 List of Abbreviation
Table 2 North America fiducial markers market, by region, 2016 - 2027 (USD Million)
Table 3 North America fiducial markers market, by product, 2016 - 2027 (USD Million)
Table 4 North America fiducial markers market, by modality, 2016 - 2027 (USD Million)
Table 5 North America fiducial markers market, by application, 2016 - 2027 (USD Million)
Table 6 North America fiducial markers market, by end-user, 2016 - 2027 (USD Million)
Table 7 U.S. fiducial markers market, by product, 2016 - 2027 (USD Million)
Table 8 U.S. fiducial markers market, by modality, 2016 - 2027 (USD Million)
Table 9 U.S. fiducial markers market, by application, 2016 - 2027 (USD Million)
Table 10 U.S. fiducial markers market, by end-user, 2016 - 2027 (USD Million)
Table 11 Canada fiducial markers market, by product, 2016 - 2027 (USD Million)
Table 12 Canada fiducial markers market, by modality, 2016 - 2027 (USD Million)
Table 13 Canada fiducial markers market, by application, 2016 - 2027 (USD Million)
Table 14 Canada fiducial markers market, by end-user, 2016 - 2027 (USD Million)
Table 15 Europe fiducial markers market, by region, 2016 - 2027 (USD Million)
Table 16 Europe fiducial markers market, by product, 2016 - 2027 (USD Million)
Table 17 Europe fiducial markers market, by modality, 2016 - 2027 (USD Million)
Table 18 Europe fiducial markers market, by application, 2016 - 2027 (USD Million)
Table 19 Europe fiducial markers market, by end-user, 2016 - 2027 (USD Million)
Table 20 U.K. fiducial markers market, by product, 2016 - 2027 (USD Million)
Table 21 U.K. fiducial markers market, by modality, 2016 - 2027 (USD Million)
Table 22 U.K. fiducial markers market, by application, 2016 - 2027 (USD Million)
Table 23 U.K. fiducial markers market, by end-user, 2016 - 2027 (USD Million)
Table 24 Germany fiducial markers market, by product, 2016 - 2027 (USD Million)
Table 25 Germany fiducial markers market, by modality, 2016 - 2027 (USD Million)
Table 26 Germany fiducial markers market, by application, 2016 - 2027 (USD Million)
Table 27 Germany fiducial markers market, by end-user, 2016 - 2027 (USD Million)
Table 28 France fiducial markers market, by product, 2016 - 2027 (USD Million)
Table 29 France fiducial markers market, by modality, 2016 - 2027 (USD Million)
Table 30 France fiducial markers market, by application, 2016 - 2027 (USD Million)
Table 31 France fiducial markers market, by end-user, 2016 - 2027 (USD Million)
Table 32 Italy fiducial markers market, by product, 2016 - 2027 (USD Million)
Table 33 Italy fiducial markers market, by modality, 2016 - 2027 (USD Million)
Table 34 Italy fiducial markers market, by application, 2016 - 2027 (USD Million)
Table 35 Italy fiducial markers market, by end-user, 2016 - 2027 (USD Million)
Table 36 Spain fiducial markers market, by product, 2016 - 2027 (USD Million)
Table 37 Spain fiducial markers market, by modality, 2016 - 2027 (USD Million)
Table 38 Spain fiducial markers market, by application, 2016 - 2027 (USD Million)
Table 39 Spain fiducial markers market, by end-user, 2016 - 2027 (USD Million)
Table 40 Russia fiducial markers market, by product, 2016 - 2027 (USD Million)
Table 41 Russia fiducial markers market, by modality, 2016 - 2027 (USD Million)
Table 42 Russia fiducial markers market, by application, 2016 - 2027 (USD Million)
Table 43 Russia fiducial markers market, by end-user, 2016 - 2027 (USD Million)
Table 44 Switzerland fiducial markers market, by product, 2016 - 2027 (USD Million)
Table 45 Switzerland fiducial markers market, by modality, 2016 - 2027 (USD Million)
Table 46 Switzerland fiducial markers market, by application, 2016 - 2027 (USD Million)
Table 47 Switzerland fiducial markers market, by end-user, 2016 - 2027 (USD Million)
Table 48 The Netherland fiducial markers market, by product, 2016 - 2027 (USD Million)
Table 49 The Netherland fiducial markers market, by modality, 2016 - 2027 (USD Million)
Table 50 The Netherland fiducial markers market, by application, 2016 - 2027 (USD Million)
Table 51 The Netherland fiducial markers market, by end-user, 2016 - 2027 (USD Million)
Table 52 Sweden fiducial markers market, by product, 2016 - 2027 (USD Million)
Table 53 Sweden fiducial markers market, by modality, 2016 - 2027 (USD Million)
Table 54 Sweden fiducial markers market, by application, 2016 - 2027 (USD Million)
Table 55 Sweden fiducial markers market, by end-user, 2016 - 2027 (USD Million)
Table 56 Belgium fiducial markers market, by product, 2016 - 2027 (USD Million)
Table 57 Belgium fiducial markers market, by modality, 2016 - 2027 (USD Million)
Table 58 Belgium fiducial markers market, by application, 2016 - 2027 (USD Million)
Table 59 Belgium fiducial markers market, by end-user, 2016 - 2027 (USD Million)
Table 60 Asia Pacific fiducial markers market, by region, 2016 - 2027 (USD Million)
Table 61 Asia Pacific fiducial markers market, by product, 2016 - 2027 (USD Million)
Table 62 Asia Pacific fiducial markers market, by modality, 2016 - 2027 (USD Million)
Table 63 Asia Pacific fiducial markers market, by application, 2016 - 2027 (USD Million)
Table 64 Asia Pacific fiducial markers market, by end-user, 2016 - 2027 (USD Million)
Table 65 Japan fiducial markers market, by product, 2016 - 2027 (USD Million)
Table 66 Japan fiducial markers market, by modality, 2016 - 2027 (USD Million)
Table 67 Japan fiducial markers market, by application, 2016 - 2027 (USD Million)
Table 68 Japan fiducial markers market, by end-user, 2016 - 2027 (USD Million)
Table 69 China fiducial markers market, by product, 2016 - 2027 (USD Million)
Table 70 China fiducial markers market, by modality, 2016 - 2027 (USD Million)
Table 71 China fiducial markers market, by application, 2016 - 2027 (USD Million)
Table 72 China fiducial markers market, by end-user, 2016 - 2027 (USD Million)
Table 73 India fiducial markers market, by product, 2016 - 2027 (USD Million)
Table 74 India fiducial markers market, by modality, 2016 - 2027 (USD Million)
Table 75 India fiducial markers market, by application, 2016 - 2027 (USD Million)
Table 76 India fiducial markers market, by end-user, 2016 - 2027 (USD Million)
Table 77 South Korea fiducial markers market, by product, 2016 - 2027 (USD Million)
Table 78 South Korea fiducial markers market, by modality, 2016 - 2027 (USD Million)
Table 79 South Korea fiducial markers market, by application, 2016 - 2027 (USD Million)
Table 80 South Korea fiducial markers market, by end-user, 2016 - 2027 (USD Million)
Table 81 Thailand fiducial markers market, by product, 2016 - 2027 (USD Million)
Table 82 Thailand fiducial markers market, by modality, 2016 - 2027 (USD Million)
Table 83 Thailand fiducial markers market, by application, 2016 - 2027 (USD Million)
Table 84 Thailand fiducial markers market, by end-user, 2016 - 2027 (USD Million)
Table 85 Indonesia fiducial markers market, by product, 2016 - 2027 (USD Million)
Table 86 Indonesia fiducial markers market, by modality, 2016 - 2027 (USD Million)
Table 87 Indonesia fiducial markers market, by application, 2016 - 2027 (USD Million)
Table 88 Indonesia fiducial markers market, by end-user, 2016 - 2027 (USD Million)
Table 89 Philippines fiducial markers market, by product, 2016 - 2027 (USD Million)
Table 90 Philippines fiducial markers market, by modality, 2016 - 2027 (USD Million)
Table 91 Philippines fiducial markers market, by application, 2016 - 2027 (USD Million)
Table 92 Philippines fiducial markers market, by end-user, 2016 - 2027 (USD Million)
Table 93 Taiwan fiducial markers market, by product, 2016 - 2027 (USD Million)
Table 94 Taiwan fiducial markers market, by modality, 2016 - 2027 (USD Million)
Table 95 Taiwan fiducial markers market, by application, 2016 - 2027 (USD Million)
Table 96 Taiwan fiducial markers market, by end-user, 2016 - 2027 (USD Million)
Table 97 Malaysia fiducial markers market, by product, 2016 - 2027 (USD Million)
Table 98 Malaysia fiducial markers market, by modality, 2016 - 2027 (USD Million)
Table 99 Malaysia fiducial markers market, by application, 2016 - 2027 (USD Million)
Table 100 Malaysia fiducial markers market, by end-user, 2016 - 2027 (USD Million)
Table 101 Singapore fiducial markers market, by product, 2016 - 2027 (USD Million)
Table 102 Singapore fiducial markers market, by modality, 2016 - 2027 (USD Million)
Table 103 Singapore fiducial markers market, by application, 2016 - 2027 (USD Million)
Table 104 Singapore fiducial markers market, by end-user, 2016 - 2027 (USD Million)
Table 105 Latin America fiducial markers market, by region, 2016 - 2027 (USD Million)
Table 106 Latin America fiducial markers market, by product, 2016 - 2027 (USD Million)
Table 107 Latin America fiducial markers market, by modality, 2016 - 2027 (USD Million)
Table 108 Latin America fiducial markers market, by application, 2016 - 2027 (USD Million)
Table 109 Latin America fiducial markers market, by end-user, 2016 - 2027 (USD Million)
Table 110 Brazil fiducial markers market, by product, 2016 - 2027 (USD Million)
Table 111 Brazil fiducial markers market, by modality, 2016 - 2027 (USD Million)
Table 112 Brazil fiducial markers market, by application, 2016 - 2027 (USD Million)
Table 113 Brazil fiducial markers market, by end-user, 2016 - 2027 (USD Million)
Table 114 Mexico fiducial markers market, by product, 2016 - 2027 (USD Million)
Table 115 Mexico fiducial markers market, by modality, 2016 - 2027 (USD Million)
Table 116 Mexico fiducial markers market, by application, 2016 - 2027 (USD Million)
Table 117 Mexico fiducial markers market, by end-user, 2016 - 2027 (USD Million)
Table 118 Argentina fiducial markers market, by product, 2016 - 2027 (USD Million)
Table 119 Argentina fiducial markers market, by modality, 2016 - 2027 (USD Million)
Table 120 Argentina fiducial markers market, by application, 2016 - 2027 (USD Million)
Table 121 Argentina fiducial markers market, by end-user, 2016 - 2027 (USD Million)
Table 122 Colombia fiducial markers market, by product, 2016 - 2027 (USD Million)
Table 123 Colombia fiducial markers market, by modality, 2016 - 2027 (USD Million)
Table 124 Colombia fiducial markers market, by application, 2016 - 2027 (USD Million)
Table 125 Colombia fiducial markers market, by end-user, 2016 - 2027 (USD Million)
Table 126 Chile fiducial markers market, by product, 2016 - 2027 (USD Million)
Table 127 Chile fiducial markers market, by modality, 2016 - 2027 (USD Million)
Table 128 Chile fiducial markers market, by application, 2016 - 2027 (USD Million)
Table 129 Chile fiducial markers market, by end-user, 2016 - 2027 (USD Million)
Table 130 Middle East and Africa fiducial markers market, by region, 2016 - 2027 (USD Million)
Table 131 Middle East and Africa fiducial markers market, by product, 2016 - 2027 (USD Million)
Table 132 Middle East and Africa fiducial markers market, by modality, 2016 - 2027 (USD Million)
Table 133 Middle East and Africa fiducial markers market, by application, 2016 - 2027 (USD Million)
Table 134 Middle East and Africa fiducial markers market, by end-user, 2016 - 2027 (USD Million)
Table 135 South Africa fiducial markers market, by product, 2016 - 2027 (USD Million)
Table 136 South Africa fiducial markers market, by modality, 2016 - 2027 (USD Million)
Table 137 South Africa fiducial markers market, by application, 2016 - 2027 (USD Million)
Table 138 South Africa fiducial markers market, by end-user, 2016 - 2027 (USD Million)
Table 139 Saudi Arabia fiducial markers market, by product, 2016 - 2027 (USD Million)
Table 140 Saudi Arabia fiducial markers market, by modality, 2016 - 2027 (USD Million)
Table 141 Saudi Arabia fiducial markers market, by application, 2016 - 2027 (USD Million)
Table 142 Saudi Arabia fiducial markers market, by end-user, 2016 - 2027 (USD Million)
Table 143 Kuwait fiducial markers market, by product, 2016 - 2027 (USD Million)
Table 144 Kuwait fiducial markers market, by modality, 2016 - 2027 (USD Million)
Table 145 Kuwait fiducial markers market, by application, 2016 - 2027 (USD Million)
Table 146 Kuwait fiducial markers market, by end-user, 2016 - 2027 (USD Million)
Table 147 UAE fiducial markers market, by product, 2016 - 2027 (USD Million)
Table 148 UAE fiducial markers market, by modality, 2016 - 2027 (USD Million)
Table 149 UAE fiducial markers market, by application, 2016 - 2027 (USD Million)
Table 150 UAE fiducial markers market, by end-user, 2016 - 2027 (USD Million)
Table 151 Israel fiducial markers market, by product, 2016 - 2027 (USD Million)
Table 152 Israel fiducial markers market, by modality, 2016 - 2027 (USD Million)
Table 153 Israel fiducial markers market, by application, 2016 - 2027 (USD Million)
Table 154 Israel fiducial markers market, by end-user, 2016 - 2027 (USD Million)

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[基準マーカーの世界市場2020-2027:モダリティ別(超音波、CT/CBCT)、製品別、用途別、エンドユーザー別]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆